|
|
||||||||
Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
Correspondence: For reprints contact: David Piwnica-Worms, MD, PhD, Department of Radiology, Brigham and Women's Hospital, 75 Francis St., Boston, MA02115.
ABSTRACT
To address the apparent discrepancy between cultured cells and whole heart preparations, Langendorff-perfused rat hearts loaded with hexakis (2-methoxyisobutyl isonitrile) techneticum (I) (99mTc-MIBI) were fractionated by a standard differential centrifugation method and fractional contents of 99mTc-MIBI were correlated with the mitochondrial marker, malate dehydrogenase (MDH), and mitochondrial substrates. The "cytosolic" fraction nominally contained 89% ± 3% of total 99mTc-MIBI, but also contained 91% ± 1% of total MDH activity by this method. Chromatographic analysis of activity in the "cytosolic" fraction demonstrated >95% of the agent was present as the original free cationic complex; binding to a small molecular weight cytosolic protein was not involved in localization. Addition of the mitochondrial uncoupler CCCP (5 µM) to both "mitochondrial" and "cell fragment" pellets released up to 84% ± 8% of 99mTc-MIBI content and addition of the mitochondrial substrate succinate (10 µM) in the presence of rotenone (1 µM) enhanced 99mTc-MIBI content by up to 139% ± 52% over the control. These correlative data from rat hearts indicate that approximately 90% of 99mTc-MIBI activity in vivo is associated with mitochondria in an energy dependent manner as a free cationic complex, but migrates during fractionation/centrifugation.
This article has been cited by other articles:
![]() |
C. Bolzati, M. Cavazza-Ceccato, S. Agostini, S. Tokunaga, D. Casara, and G. Bandoli Subcellular Distribution and Metabolism Studies of the Potential Myocardial Imaging Agent [99mTc(N)(DBODC)(PNP5)]+ J. Nucl. Med., August 1, 2008; 49(8): 1336 - 1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wei, J. Easmon, R. K. Nagi, B. D. Muegge, L. A. Meyer, and J. S. Lewis 64Cu-Azabicyclo[3.2.2]Nonane Thiosemicarbazone Complexes: Radiopharmaceuticals for PET of Topoisomerase II Expression in Tumors J. Nucl. Med., December 1, 2006; 47(12): 2034 - 2041. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Polan, B. D. Klein, and R. H. Richman Scintimammography in Patients with Minimal Mammographic or Clinical Findings RadioGraphics, May 1, 2001; 21(3): 641 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Olaizola, J. Zingraff, C. Heuguerot, L. Fajardo, A. Leger, J. Lopez, G. Acuna, A. Petraglia, A. Alvarez, H. Caorsi, et al. [99mTc]-Sestamibi parathyroid scintigraphy in chronic haemodialysis patients: static and dynamic explorations Nephrol. Dial. Transplant., August 1, 2000; 15(8): 1201 - 1206. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lagana, O. Schillaci, L. Tubani, R. Gentile, R. Danieli, R. Coviello, L. Baratta, F. Scopinaro, and B. Lagana Lupus Carditis: Evaluation with Technetium-99m MIBI Myocardial SPECT and Heart Rate Variability Angiology, February 1, 1999; 50(2): 143 - 148. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |